Cabaletta Bio Inc (NASDAQ: CABA) on Friday, plunged -3.73% from the previous trading day, before settling in for the closing price of $1.61. Within the past 52 weeks, CABA’s price has moved between $1.45 and $19.04.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
The company achieved an average annual earnings per share of -41.74%. With a float of $44.47 million, this company’s outstanding shares have now reached $48.85 million.
The firm has a total of 103 workers. Let’s measure their productivity. In terms of profitability, gross margin is 71.2%, operating margin of -2855.41%, and the pretax margin is -2597.61%.
Cabaletta Bio Inc (CABA) Breakdown of a Key Holders of the stock
Observing investor behavior towards Biotechnology industry stocks is more important than anything else. The insider ownership of Cabaletta Bio Inc is 9.03%, while institutional ownership is 74.15%.
Cabaletta Bio Inc (CABA) Recent Fiscal highlights
Wall Street market experts anticipate that the next fiscal year will bring earnings of -0.67 per share during the current fiscal year.
According to the Wall Street analysts, stocks earnings will be around -41.74% per share during the next fiscal year. For the long-term projections, market analysts anticipate that the company’s EPS will plunge by -17.12% during the next five years compared to -26.63% drop over the previous five years of trading.
Cabaletta Bio Inc (NASDAQ: CABA) Trading Performance Indicators
Cabaletta Bio Inc (CABA) is currently performing well based on its current performance indicators. A quick ratio of 8.11 was reported for the most recent quarter.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -2.16, a number that is poised to hit -0.64 in the next quarter and is forecasted to reach -2.54 in one year’s time.
Technical Analysis of Cabaletta Bio Inc (CABA)
Analysing the last 5-days average volume posted by the [Cabaletta Bio Inc, CABA], we can find that recorded value of 0.89 million was lower than the volume posted last year of 1.19 million. As of the previous 9 days, the stock’s Stochastic %D was 30.54%. Additionally, its Average True Range was 0.16.
During the past 100 days, Cabaletta Bio Inc’s (CABA) raw stochastic average was set at 2.49%, which indicates a significant decrease from 17.84% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 66.27% in the past 14 days, which was lower than the 119.88% volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $2.1079, while its 200-day Moving Average is $4.2003. Now, the first resistance to watch is $1.6117. This is followed by the second major resistance level at $1.6733. The third major resistance level sits at $1.7317. If the price goes on to break the first support level at $1.4917, it is likely to go to the next support level at $1.4333. Now, if the price goes above the second support level, the third support stands at $1.3717.
Cabaletta Bio Inc (NASDAQ: CABA) Key Stats
Market capitalization of the company is 75.76 million based on 48,877K outstanding shares. Right now, sales total 0 K and income totals -67,680 K. The company made 0 K in profit during its latest quarter, and -30,630 K in sales during its previous quarter.
